Jul 16 |
Viridian, Pharvaris said to be among prime M&A targets for Biogen
|
Jul 16 |
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
|
Jul 13 |
Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A
|
Jul 13 |
Biogen's Diverse Drug Portfolio Faces Competitive Challenges In 2024
|
Jul 11 |
Biogen Stock: Cheapish, But With Few Growth Prospects
|
Jul 11 |
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
|
Jul 5 |
3 Highly Rated Biotech Stocks for Your July Buy List
|
Jul 3 |
Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
|
Jul 3 |
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
|
Jul 2 |
Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
|